WO2002092001A3 - Compositions et methodes de traitement et de diagnostic du cancer du poumon - Google Patents
Compositions et methodes de traitement et de diagnostic du cancer du poumon Download PDFInfo
- Publication number
- WO2002092001A3 WO2002092001A3 PCT/US2002/014975 US0214975W WO02092001A3 WO 2002092001 A3 WO2002092001 A3 WO 2002092001A3 US 0214975 W US0214975 W US 0214975W WO 02092001 A3 WO02092001 A3 WO 02092001A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compositions
- diagnosis
- lung cancer
- therapy
- polypeptides
- Prior art date
Links
- 208000020816 lung neoplasm Diseases 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 title abstract 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 title abstract 3
- 238000003745 diagnosis Methods 0.000 title abstract 3
- 201000005202 lung cancer Diseases 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 4
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 4
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 210000000612 antigen-presenting cell Anatomy 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000002163 immunogen Effects 0.000 abstract 1
- 208000037841 lung tumor Diseases 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
- A61K2239/55—Lung
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/463—Cellular immunotherapy characterised by recombinant expression
- A61K39/4632—T-cell receptors [TCR]; antibody T-cell receptor constructs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Cell Biology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Hospice & Palliative Care (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002311909A AU2002311909A1 (en) | 2001-05-11 | 2002-05-10 | Compositions and methods for the therapy and diagnosis of lung cancer |
EP02739247A EP1516049A4 (fr) | 2001-05-11 | 2002-05-10 | Compositions et methodes de traitement et de diagnostic du cancer du poumon |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/854,133 US6759508B2 (en) | 2000-09-01 | 2001-05-11 | Compositions and methods for the therapy and diagnosis of lung cancer |
US09/854,133 | 2001-05-11 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002092001A2 WO2002092001A2 (fr) | 2002-11-21 |
WO2002092001A3 true WO2002092001A3 (fr) | 2005-01-13 |
Family
ID=25317820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2002/014975 WO2002092001A2 (fr) | 2001-05-11 | 2002-05-10 | Compositions et methodes de traitement et de diagnostic du cancer du poumon |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1516049A4 (fr) |
AU (1) | AU2002311909A1 (fr) |
WO (1) | WO2002092001A2 (fr) |
Families Citing this family (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003243151A1 (en) | 2002-08-16 | 2004-03-03 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
US7226791B2 (en) * | 2003-06-02 | 2007-06-05 | Bristol-Myers Squibb Company | Polynucleotides encoding novel guanylate binding proteins (GBP's) |
CN106039307A (zh) | 2008-08-05 | 2016-10-26 | 东丽株式会社 | 用于治疗和预防癌症的药物组合物 |
KR101606779B1 (ko) * | 2008-08-05 | 2016-03-28 | 도레이 카부시키가이샤 | 암의 검출 방법 |
CN102821788B (zh) | 2010-02-04 | 2016-11-16 | 东丽株式会社 | 癌的治疗和/或预防用药物组合物 |
KR101843807B1 (ko) | 2010-02-04 | 2018-03-30 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방을 위한 의약품 |
CN102822335B (zh) | 2010-02-04 | 2015-09-30 | 东丽株式会社 | 癌的治疗和/或预防用药物组合物 |
HUE030102T2 (en) | 2010-02-04 | 2017-04-28 | Toray Industries | A pharmaceutical composition comprising anti-caprin-1 antibodies for the treatment and / or prevention of cancer |
KR101758117B1 (ko) | 2010-02-04 | 2017-07-14 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
BR112012018951C8 (pt) | 2010-02-04 | 2020-06-23 | Toray Industries | anticorpo monoclonal, composição farmacêutica, combinação farmacêutica, uso de um anticorpo, uso de uma composição farmacêutica e uso de uma combinação farmacêutica |
EP2740793B1 (fr) | 2011-08-04 | 2017-11-29 | Toray Industries, Inc. | Composition de médicament pour traitement et/ou prévention du cancer |
WO2013018894A1 (fr) | 2011-08-04 | 2013-02-07 | 東レ株式会社 | Composition pharmaceutique destinée à traiter ou à prévenir le cancer |
DK2740794T3 (en) | 2011-08-04 | 2018-06-14 | Toray Industries | PHARMACEUTICAL COMPOSITION FOR TREATMENT AND / OR CANCER PREVENTION |
KR101980554B1 (ko) | 2011-08-04 | 2019-05-21 | 도레이 카부시키가이샤 | 암의 치료 및/또는 예방용 의약 조성물 |
JP6065592B2 (ja) | 2011-08-04 | 2017-01-25 | 東レ株式会社 | 癌の治療及び/又は予防用医薬組成物 |
HUE033628T2 (en) | 2011-08-04 | 2017-12-28 | Toray Industries | Method for detecting pancreatic cancer |
MX351414B (es) | 2011-08-04 | 2017-10-13 | Toray Industries | Composicion farmaceutica para el tratamiento y/o prevencion de cancer pancreatico. |
BR112014021103A2 (pt) | 2012-02-21 | 2019-10-15 | Toray Industries, Inc | Anticorpo, composição farmacêutica, droga de combinação, dna, método de tratamento e uso de anticorpo |
EP2818482B1 (fr) | 2012-02-21 | 2019-05-22 | Toray Industries, Inc. | Composition pharmaceutique pour le traitement du cancer |
MX363136B (es) | 2012-02-21 | 2019-03-12 | Toray Industries | Composicion farmaceutica para el tratamiento y/o prevencion del cancer. |
PL2818483T3 (pl) | 2012-02-21 | 2018-01-31 | Toray Industries | Kompozycja lecznicza do leczenia i/lub zapobiegania nowotworowi |
KR102052400B1 (ko) | 2012-03-30 | 2019-12-06 | 도레이 카부시키가이샤 | 담낭암의 치료 및/또는 예방용 의약 조성물 |
HUE036424T2 (hu) | 2012-03-30 | 2018-07-30 | Toray Industries | Gyógyászati készítmény májrák kezelésére és/vagy megelõzésére |
CA2879185C (fr) | 2012-07-19 | 2021-08-24 | Toray Industries, Inc. | Procede de detection de cancer |
WO2014014082A1 (fr) | 2012-07-19 | 2014-01-23 | 東レ株式会社 | Procédé de détection de cancer |
CN105452294B (zh) | 2013-08-09 | 2019-08-02 | 东丽株式会社 | 癌的治疗和/或预防用药物组合物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5834248A (en) * | 1995-02-10 | 1998-11-10 | Millennium Pharmaceuticals Inc. | Compositions and methods using rchd534, a gene uregulated by shear stress |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA02000192A (es) * | 1999-06-30 | 2004-08-12 | Corixa Corp | Composiciones y metodos para la terapia y diagnostico de cancer de pulmon. |
AU2001261007A1 (en) * | 2000-03-29 | 2001-10-08 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
WO2001096390A2 (fr) * | 2000-06-09 | 2001-12-20 | Corixa Corporation | Compositions et procedes pour la therapie et le diagnostic du cancer du colon |
-
2002
- 2002-05-10 EP EP02739247A patent/EP1516049A4/fr not_active Withdrawn
- 2002-05-10 WO PCT/US2002/014975 patent/WO2002092001A2/fr active Search and Examination
- 2002-05-10 AU AU2002311909A patent/AU2002311909A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5834248A (en) * | 1995-02-10 | 1998-11-10 | Millennium Pharmaceuticals Inc. | Compositions and methods using rchd534, a gene uregulated by shear stress |
Also Published As
Publication number | Publication date |
---|---|
EP1516049A4 (fr) | 2006-01-11 |
AU2002311909A1 (en) | 2002-11-25 |
EP1516049A2 (fr) | 2005-03-23 |
WO2002092001A2 (fr) | 2002-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2001072295A3 (fr) | Compositions et methodes pouvant traiter ou diagnostiquer le cancer du poumon | |
WO2002060317A3 (fr) | Compositions et methodes pour le traitement et le diagnostic du cancer du pancreas | |
WO2002074156A8 (fr) | Compositions et procedes de therapie et de diagnostic du cancer du colon | |
WO2001092581A8 (fr) | Compositions et methodes permettant le traitement et le diagnostic du cancer de l'ovaire | |
WO2002089747A3 (fr) | Compositions et procedes pour la therapie et le diagnostic du cancer de la prostate | |
WO2002092001A3 (fr) | Compositions et methodes de traitement et de diagnostic du cancer du poumon | |
WO2004052276A3 (fr) | Compositions et procedes pour la therapie et le diagnostic du cancer de la prostate | |
WO2002004514A8 (fr) | Compositions et procedes pour le traitement et le diagnostic du cancer du poumon | |
WO2001051633A3 (fr) | Compositions et methodes destinees au traitement et au diagnostique du cancer de la prostate | |
WO2001073032A3 (fr) | Compositions et methodes de therapie et de diagnostic du cancer de la prostate | |
WO2002016413A8 (fr) | Vaccins | |
WO2002074237A3 (fr) | Compositions et procedes de therapie et de diagnostic du cancer du rein | |
WO2002012328A3 (fr) | Compositions et methodes utilisees dans la therapie et le diagnostic du cancer du colon | |
WO2006031363A3 (fr) | Compositions et procedes pour la therapie et le diagnostic du cancer du poumon | |
WO2003037267A8 (fr) | Compositions et methodes de traitement et de diagnostic du cancer des poumons | |
WO2002078516A3 (fr) | Compositions et methodes de traitement et de diagnostic de cancers | |
WO2002058534A3 (fr) | Compositions et methodes pour le traitement et le diagnostic du cancer du colon | |
WO2001077168A3 (fr) | Compositions et procedes permettant de traiter et de diagnostiquer le cancer du poumon | |
WO2003013431A3 (fr) | Compositions et techniques de therapie et de diagnostic du cancer du sein | |
WO2002039885A3 (fr) | Compositions et methodes destinees a la therapie et au diagnostic du cancer de l'ovaire | |
WO2002012280A3 (fr) | Compositions et procedes pour le diagnostic et le traitement du cancer du colon | |
WO2001090152A3 (fr) | Compositions et procedes pour la therapie et le diagnostic du cancer du sein | |
WO2002000174A3 (fr) | Compositions et methodes pour le traitement et le diagnostic du cancer du poumon | |
WO2003086175A8 (fr) | Compositions et procedes destines au traitement et au diagnostic du cancer du poumon | |
WO2005051990A3 (fr) | Compositions et procedes pour le traitement et le diagnostic du cancer du sein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002739247 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWP | Wipo information: published in national office |
Ref document number: 2002739247 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
DPE2 | Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101) |